Caplin Point Laboratories Limited Share Price NSE India S.E.
Equities
CAPLIPOINT
INE475E01026
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,457.00 INR | +3.05% | +4.06% | +81.28% |
08/11 | Caplin Point Laboratories Limited Announces Cessation of D Sathyanarayanan as an Independent Director | CI |
07/11 | Caplin Point Laboratories Limited, H1 2025 Earnings Call, Nov 07, 2024 |
Capitalization | 18TCr 213.63Cr 203.33Cr 188.43Cr 167.6Cr 302.54Cr 335.29Cr 2.35TCr 866.14Cr 7.44TCr 802.01Cr 784.71Cr 32TCr | P/E ratio 2025 * |
35.7x | P/E ratio 2026 * | 31.2x |
---|---|---|---|---|---|
Enterprise value | 18TCr 213.63Cr 203.33Cr 188.43Cr 167.6Cr 302.54Cr 335.29Cr 2.35TCr 866.14Cr 7.44TCr 802.01Cr 784.71Cr 32TCr | EV / Sales 2025 * |
9.22x | EV / Sales 2026 * | 8.1x |
Free-Float |
25.42% | Yield 2025 * |
0.14% | Yield 2026 * | 0.15% |
Last Transcript: Caplin Point Laboratories Limited
1 day | +3.11% | ||
1 week | +4.06% | ||
Current month | +11.93% | ||
1 month | +22.18% | ||
3 months | +25.11% | ||
6 months | +68.53% | ||
Current year | +81.28% |
Director | Title | Age | Since |
---|---|---|---|
Sridhar Ganesan
CEO | Chief Executive Officer | 69 | 28/03/2015 |
D. Muralidharan
DFI | Director of Finance/CFO | - | 19/02/2016 |
Chief Tech/Sci/R&D Officer | - | 11/06/2024 |
Manager | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 27/01/2010 | |
Sridhar Ganesan
BRD | Director/Board Member | 69 | 28/03/2015 |
C. K. Gariyali
BRD | Director/Board Member | 75 | 04/03/2020 |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+3.05% | +4.06% | - | - | 213.63Cr | ||
+0.39% | +0.93% | +46.36% | +138.26% | 5.12TCr | ||
-0.66% | -2.26% | +53.47% | +112.76% | 3.12TCr | ||
+0.42% | -1.92% | +39.52% | - | 1.88TCr | ||
+0.05% | -3.00% | +21.08% | +63.33% | 1.38TCr | ||
+1.41% | +1.83% | +55.95% | +112.61% | 1.16TCr | ||
-.--% | +0.14% | - | - | 678.76Cr | ||
-.--% | -1.95% | - | - | 572.55Cr | ||
+0.15% | -1.26% | -33.88% | -38.13% | 531.44Cr | ||
-0.03% | -0.23% | +4.45% | +20.22% | 523.68Cr | ||
Average | +0.48% | -1.66% | +26.71% | +68.17% | 1.66TCr | |
Weighted average by Cap. | +0.21% | -1.61% | +40.58% | +107.11% |
2025 * | 2026 * | |
---|---|---|
Net sales | 1.97TCr 23Cr 22Cr 20Cr 18Cr 33Cr 36Cr 254.51Cr 94Cr 807.46Cr 87Cr 85Cr 3.52TCr | 2.24TCr 26Cr 25Cr 23Cr 21Cr 37Cr 41Cr 289.51Cr 106.87Cr 918.5Cr 99Cr 97Cr 4.01TCr |
Net income | 506.87Cr 5.97Cr 5.68Cr 5.27Cr 4.69Cr 8.46Cr 9.37Cr 66Cr 24Cr 208.13Cr 22Cr 22Cr 908.25Cr | 580.63Cr 6.84Cr 6.51Cr 6.04Cr 5.37Cr 9.69Cr 11Cr 75Cr 28Cr 238.42Cr 26Cr 25Cr 1.04TCr |
Net Debt | - | - |
Date | Price | Change | Volume |
---|---|---|---|
11/24/11 | 2,457.00 ₹ | +3.05% | 204,908 |
10/24/10 | 2,384.35 ₹ | -0.06% | 76,389 |
09/24/09 | 2,385.90 ₹ | +1.33% | 139,725 |
06/24/06 | 2,354.65 ₹ | -1.09% | 201,865 |
05/24/05 | 2,380.50 ₹ | +0.76% | 548,056 |
Delayed Quote NSE India S.E., December 11, 2024 at 02:08 pm IST
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- CAPLIPOINT Stock
- CAPLIPOINT Stock
MarketScreener is also available in this country: United States.
Switch edition